Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$6.66 - $10.64 $6,233 - $9,959
936 New
936 $7,000
Q1 2022

May 09, 2022

SELL
$13.42 - $29.73 $432,150 - $957,365
-32,202 Closed
0 $0
Q4 2021

Feb 01, 2022

BUY
$27.59 - $66.39 $888,453 - $2.14 Million
32,202 New
32,202 $944,000
Q4 2020

Feb 16, 2021

SELL
$47.41 - $115.03 $158,918 - $385,580
-3,352 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$43.0 - $84.01 $144,136 - $281,601
3,352 New
3,352 $247,000
Q2 2020

Aug 14, 2020

SELL
$51.3 - $75.21 $447,438 - $655,981
-8,722 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$31.51 - $73.75 $274,830 - $643,247
8,722 New
8,722 $490,000

Others Institutions Holding IGMS

About IGM Biosciences, Inc.


  • Ticker IGMS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,969,000
  • Market Cap $189M
  • Description
  • IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...
More about IGMS
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.